Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
The company plans to expand its portfolio in regulated markets aggressively
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
The first clinical trial is expected to commence in early 2022 both in Europe and the US
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
The company plans to submit the IND application by the end of 2021
This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption
The acquisition complements and strengthens Merck’s cardiovascular pipeline
These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products
Subscribe To Our Newsletter & Stay Updated
